JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toner, J. J.
Right arrow Articles by Macko, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toner, J. J.
Right arrow Articles by Macko, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 106, Issue 2, 246-251, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


PHARMACOLOGY STUDIES ON BIS-(1-CARBO-beta-DIETHYL-AMINOETHOXY)-1-PHENYLCYCLOPENTANE)-ETHANE DISULFONATE

J. J. Toner 1 and E. Macko 1

1 Research and Development Division, Smith, Kline & French Laboratories, Philadelphia, Pa.

1. 6-Dimethylamino-4,4-diphenyl-3-heptanone hydrochloride, codeine and bis-(1-(carbo-beta-diethylaminoethoxy)-1-phenyl-cyclopentane)-ethane disulfonate (SKF No. 769-J2) were found to exhibit antitussive activity when tested by a modification of the Domenjoz method. 3,3-Diethyl-2,4-dioxopiperidine was ineffective in doses up to 100 mgm./kgm.

2. In effective antitussive doses, SKF No. 769-J2 produced either an increase or slight decrease in respiratory volume in dogs, whereas codeine caused a marked decrease.

3. SKF No. 769-J2 had 1/2 to 1/10 the antispasmodic activity of atropine on the isolated rabbit intestine, and 1/2 the local anesthetic activity of cocaine on the rabbit cornea.

4. In subacute and chronic toxicity studies, no evidence of changes due to administration of SKF No. 769-J2 was observed by histological examination of tissues removed from rats and dogs which received massive daily doses of this compound for periods of 1 to 3 months.

5. The data obtained in the present experiments indicate that SKF No. 769-J2 should be evaluated clinically as an antitussive agent.

Submitted on June 27, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.